Vaccine design based on Live attenuated cells of Toxoplasma gondii: a review

Authors

  • Abdolrazagh Marzban Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
  • Javad Akhtari Department of Physiology and Pharmacology, Immunogenetics Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
  • Javad Koshki Lorestan Provincial Veterinary Service, Khorramabad, Iran
  • Kobra Moradpour Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
  • Mohammad Ali Mohaghegh Department of Laboratory Sciences, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
  • Nader Pestechian Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  • Omid Mardanshah Department of Laboratory Sciences, Sirjan Faculty of Medical Sciences, Sirjan, Iran
Abstract:

Toxoplasma gondii is well- known as a common parasite with high proliferative activity in the nucleated cells. This parasite has infected nearly one third of the people worldwide. Infection can result in chorioretinitis in immunocompetent hosts, encephalitis in HIV/AIDS positive patients and abortion and neonatal loss in congenital toxoplasmosis. Development of vaccines for toxoplasmosis infection is very important for decreasing infection transmission routes of the disease in various host species in the world. Live attenuated vaccines are closest to a natural infection; therefore, they are good rescuers of the immune system and often create lifelong immunity with only one or two doses. In this study, the researchers reviewed the current status in the development of live attenuated vaccines on Toxoplasma infection.  

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

A review of prophylactic measure against brucellosis in human with a live attenuated vaccine

full text

Live attenuated influenza vaccine--a review.

Owing to the variability of influenza viruses, vaccine composition needs to be up-dated annually. As many variables can influence their efficacy, vaccines are still considered "sub-optimal". Many studies have been carried out in recent years to improve vaccines. In particular, researchers and vaccine-producing corporations have focused on developing a live vaccine. Among the candidate vaccines,...

full text

Development of a New Live Attenuated Mumps Virus Vaccine in Human Deploid Cells

full text

Development of an Attenuated Live Virus Vaccine against Sheep Pox

full text

Review articles Toxoplasma gondii and mast cells

Mast cells, discovered by Paul Burnet over one century ago, have been long recognized only as inductors of IgE-dependent allergic diseases (allergy of type I, Th2 lymphocytes dependent). However, numerous recent studies have indicated that they play an essential role in many other immunological and non-immunological processes. Infection with Toxoplasma gondii elicits the induction of a strong c...

full text

Experimental study of a further attenuated live measles vaccine of the Sugiyama strain in Iran

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 5  issue 4

pages  0- 0

publication date 2017-11

{@ msg @}

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023